Nakorn Premsri, director of the National Vaccine Institute, said a Thai company, Siam BioScience, was supposed to provide the country with 10 million doses per month of locally produced AstraZeneca vaccine, but this was reduced to 5 to 6 million of doses. The company, owned by the King of Thailand, is said to have had production problems. It also has contracts to supply vaccines to other countries.
–
Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it using programmatic technology on the site and not from a human editor.
–
–
–
– –
